AKT1 and cancer: Decreased m6A has been reported to impair the translation of PHLPP2 and increase the translation of mTORC2, resulting in AKT hyperactivity [216]; increased methylation and decreased translation of PTEN mRNA bring about the same effect in many other cancers [217].